BIOREM Inc.
BRM.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -39.03% | 104.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -39.03% | 104.56% | |||
| Cost of Revenue | -23.77% | 75.36% | |||
| Gross Profit | -69.00% | 203.99% | |||
| SG&A Expenses | -36.51% | 76.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -851.61% | -- | |||
| Total Operating Expenses | -26.21% | 75.24% | |||
| Operating Income | -89.18% | 492.37% | |||
| Income Before Tax | -92.17% | 547.14% | |||
| Income Tax Expenses | -91.51% | 547.49% | |||
| Earnings from Continuing Operations | -92.41% | 547.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -92.41% | 547.28% | |||
| EBIT | -89.18% | 492.37% | |||
| EBITDA | -87.68% | 448.60% | |||
| EPS Basic | -92.33% | 543.67% | |||
| Normalized Basic EPS | -92.14% | 540.74% | |||
| EPS Diluted | -119.31% | 555.30% | |||
| Normalized Diluted EPS | -90.72% | 542.98% | |||
| Average Basic Shares Outstanding | -0.89% | 0.65% | |||
| Average Diluted Shares Outstanding | -16.00% | 0.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||